These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 220657)

  • 1. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
    Bowers MB; Study RE
    Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF.
    Zarcone V; Schreier L; Barchas J; Orenberg E; Benson K
    Adv Exp Med Biol; 1977; 85A():593-9. PubMed ID: 200121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.
    Winsberg BG; Sverd J; Castells S; Hurwic M; Perel JM
    Neuropediatrics; 1980 Aug; 11(3):250-5. PubMed ID: 6158716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probenecid-induced accumulation of cyclic nucleotides, 5-hydroxyindoleacetic acid, and homovanillic acid in cisternal spinal fluid of genetically nervous dogs.
    Angel C; Deluca DC; Murphree OD
    Biol Psychiatry; 1976 Dec; 11(6):743-53. PubMed ID: 187258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space.
    Van der Poel FW; Van Praag HM; Korf J
    Psychopharmacology (Berl); 1977 Mar; 52(1):35-40. PubMed ID: 403555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amphetamine and chlordiazepoxide on probenecid-induced accumulation of acidic metabolites in the cerebrospinal fluid of the dog.
    DeLuca DC; Angel C; Murphree OD
    Biol Psychiatry; 1977 Aug; 12(4):577-82. PubMed ID: 196692
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.
    Bowers MB; Moore D; Tarsy D
    Psychopharmacology (Berl); 1979 Mar; 61(2):137-41. PubMed ID: 220654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients.
    Jori A; Dolfini E; Casati C; Argenta G
    Psychopharmacologia; 1975 Oct; 44(1):87-90. PubMed ID: 1105628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cerebrospinal monoamine metabolites in children using the probenecid method.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Isr Ann Psychiatr Relat Discip; 1977; 15(1):47-57. PubMed ID: 268307
    [No Abstract]   [Full Text] [Related]  

  • 19. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 20. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.